Formidable Asset Management
HQL icon

Formidable Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

Formidable Asset Management’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.33M Buy
166,324
+1,081
+0.7% +$21.9K 0.49% 41
2026
Q2 		$2.69M Buy
165,243
+6,858
+4% +$121K 0.43% 47
2026
Q1 		$2.66M Buy
158,385
+33,940
+27% +$567K 0.41% 45
2025
Q4 		$1.93M Buy
124,445
+48,252
+63% +$811K 0.28% 66
2025
Q3 		$976K Buy
76,193
+12,214
+19% +$167K 0.15% 132
2025
Q2 		$812K Hold
63,979
– – 0.14% 140
2025
Q1 		$812K Buy
+63,979
New +$866K 0.14% 143

Other funds holding HQL

Flagship Harbor Advisors
Flagship Harbor Advisors Boston, Massachusetts $2.69B AUM 15.82% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
180 Wealth Advisors
180 Wealth Advisors Federal Way, Washington $1.04B AUM 41.44% 1-Year Est. Return
Blue Bell Private Wealth Management
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $840M AUM 13.7% 1-Year Est. Return
UHLMANN PRICE SECURITIES
UHLMANN PRICE SECURITIES Skokie, Illinois $1.86B AUM 66.72% 1-Year Est. Return
City of London Investment Management
City of London Investment Management London, United Kingdom $1.47B AUM 36.54% 1-Year Est. Return
Closed-End Fund Advisors
Closed-End Fund Advisors Richmond, Virginia $96.2M AUM 6.01% 1-Year Est. Return
PMG Family Office
PMG Family Office Plano, Texas $108M AUM 8.93% 1-Year Est. Return
KPP Advisory Services
KPP Advisory Services Louisville, Kentucky $594M AUM 20.44% 1-Year Est. Return
Wedbush Securities
Wedbush Securities Los Angeles, California $3.95B AUM 25.45% 1-Year Est. Return

Formidable Asset Management's HQL Position: Q3 2026 in Review

Formidable Asset Management increased its abrdn Life Sciences Investors (HQL) stake by 0.65% in Q3 2026, buying an estimated $21.9K and bringing the position to 166,324 shares worth $3.33M. The position accounts for 0.49% of the portfolio, ranked #41.

Formidable Asset Management first reported a position in HQL in Q1 2025 and has held it in 7 quarters since. 35 funds tracked by Wall St. Rank hold HQL as of Q3 2026.

  • Formidable Asset Management held 166,324 shares of abrdn Life Sciences Investors worth $3.33M as of Q3 2026.
  • Formidable Asset Management bought 1,081 abrdn Life Sciences Investors shares in Q3 2026, an estimated $21.9K.
  • abrdn Life Sciences Investors made up 0.49% of Formidable Asset Management's portfolio in Q3 2026, its #41 holding.
  • Formidable Asset Management first reported a position in abrdn Life Sciences Investors in Q1 2025 and has held it in 7 quarters since.
  • 35 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2026.

Based on Formidable Asset Management's 13F filing for Q3 2026, filed 3 Nov 2026.